FDA Inspection 930451 — Mercy Research IRB

Mercy Research IRB — FEI 1926975

The FDA completed an inspection of Mercy Research IRB on Jun 15, 2015 in Chesterfield, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 15, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chesterfield, MO (United States)

Additional Details

IRB

Citations

IDCFRDescription
729021 CFR 56.108(c)Members present for review
731821 CFR 56.115(a)(2)Minutes of IRB meetings
738821 CFR 50.25(a)(2)Reasonably foreseeable risks or discomforts
739021 CFR 50.25(a)(4)Alternate procedures, courses of treatment